-
1Academic Journal
المؤلفون: P. A. Mihajlova, A. A. Adamova, Yu. E. Generalova, P. P. Snetkov, S. N. Morozkina, П. А. Михайлова, А. А. Адамова, Ю. Э. Генералова, П. П. Снетков, С. Н. Морозкина
المساهمون: The work was completed by the grant of the Russian Science Foundation (project № 21-74-20093). Link to project information: https://rscf.ru/en/project/21-74-20093/, Работа выполнена за счет гранта Российского научного фонда (проект № 21-74-20093). Ссылка на информацию о проекте: https://rscf.ru/en/project/21-74-20093/
المصدر: Drug development & registration; Том 13, № 1 (2024); 75-80 ; Разработка и регистрация лекарственных средств; Том 13, № 1 (2024); 75-80 ; 2658-5049 ; 2305-2066
مصطلحات موضوعية: система доставки, diflunisal, hyaluronic acid, polymer matrix, release, delivery system, дифлунизал, гиалуроновая кислота, полимерная матрица, высвобождение
وصف الملف: application/pdf
Relation: https://www.pharmjournal.ru/jour/article/view/1735/1245; https://www.pharmjournal.ru/jour/article/downloadSuppFile/1735/2079; Kopishinskaia S. V. Transthyretin familial amyloid polyneuropathy. Journal of Neurology and Psychiatry of S. S. Korsakov. 2018;118(10):82–89. (In Russ.) DOI:10.17116/jnevro201811810182.; Adams D., Suhr O. B., Hund E., Obici L., Tournev I., Campistol J. M., Slama M. S., Hazenberg B. P., Coelho T. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Current Opinion in Neurology. 2016;29:14–26. DOI:10.1097/WCO.0000000000000289.; Sekijima Y., Tojo K., Morita H., Koyama J., Ikeda S. Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis. Amyloid. 2015;22:79–83. DOI:10.3109/13506129.2014.997872.; Ikram A., Donnelly J. P., Sperry B. W., Samaras C., Valent J., Hanna M. Diflunisal tolerability in transthyretin cardiac amyloidosis: A single center’s experience. Amyloid. 2018;25:197–202. DOI:10.1080/13506129.2018.1519507.; Rosenblum H., Castano A., Alvarez J., Goldsmith J., Helmke S., Maurer M. S. TTR (transthyretin) stabilizers are associated with improved survival in patients with TTR cardiac amyloidosis. Circulation: Heart Failure. 2018;11:e004769. DOI:10.1161/CIRCHEARTFAILURE.117.004769.; Amanpreet K., Shishu G., Katare O. P. Formulation, characterisation and in vivo evaluation of lipid-based nanocarrier for topical delivery of diflunisal. Journal of Microencapsulation. 2016;33:475–486. DOI:10.1080/02652048.2016.1216189.; Rochín-Wong S., Rosas-Durazo A., Zavala-Rivera P., Maldonado A., Martínez-Barbosa M. E., Vélaz I., Tánori J. Drug Release Properties of Diflunisal from Layer-By-Layer Self-Assembled κ-Carrageenan/Chitosan Nanocapsules: Effect of Deposited Layers. Polymers. 2018;10(7):760. DOI:10.3390/polym10070760.; Figueroa-Pizano M. D., Vélaz I., Martínez-Barbosa M. E. A Freeze-Thawing Method to Prepare Chitosan-Poly(vinyl alcohol) Hydrogels Without Crosslinking Agents and Diflunisal Release Studies. Journal of Visualized Experiments. 2020;155:e59636. DOI:10.3791/59636.; Bashir M., Syed H. K., Asghar S., Irfan M., Almalki W. H., Menshawi S. A., Khan I. U., Shah P. A., Khalid I., Ahmad J., Gohar U. F., Peh K. K., Iqbal M. S. Effect of Hydrophilic Polymers on Complexation Efficiency of Cyclodextrins in Enhancing Solubility and Release of Diflunisal. Polymers. 2020;12:1564. DOI:10.3390/polym12071564.; Zhong Z., Yang X., Fu X. B., Yao Y. F., Guo B. H., Huang Y., Xu J. Crystalline inclusion complexes formed between the drug diflunisal and block copolymers. Chinese Chemical Letters. 2017;28:1268–1275. DOI:10.1016/j.cclet.2017.04.001.; Kegley Z., Makay M., Rogers J., Phelps K., Malcom C., Hellmig D., Kroninger A., Bi X. Polyamidoamine dendrimer-polyethylene glycol hydrogel for solubility enhancement and sustained release of diflunisal. Journal of Sol-Gel Science and Technology. 2022;104:160–168. DOI:10.1007/s10971-022-05904-y.; How K. N., Yap W. H., Lim C. L. H., Goh B. H., Lai Z. W. Hyaluronic Acid-Mediated Drug Delivery System Targeting for Inflammatory Skin Diseases: A Mini Review. Front Pharmacol. 2020;11:1105. DOI:10.3389/fphar.2020.01105.; Chen Z. What’s new about the mechanism of methotrexate action in psoriasis? British Journal of Dermatology. 2018;179(4):818–819. DOI:10.1111/bjd.16908.; Gupta R. C., Lall R., Srivastava A., Sinha A. Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory. Frontiers in Veterinary Science. 2019;6:192. DOI:10.3389/fvets.2019.00192.; Snetkov P., Morozkina S., Olekhnovich R., Vu T. H. N., Tyanutova M., Uspenskaya M. Curcumin/Usnic Acid-Loaded Electrospun Nanofibers Based on Hyaluronic Acid. Materials. 2020;13(16):3476. DOI:10.3390/ma13163476.; Cavallaro G., Pierro P., Palumbo F. S., Testa F., Pasqua L., Aiello R. Drug delivery devices based on mesoporous silicate. Drug Delivery. 2004;11(1):41–46. DOI:10.1080/10717540490265252.; Bashir M., Ahmad J., Asif M., Khan S. U. D., Irfan M., Ibrahim A. Y., Asghar S., Khan I. U., Iqbal M. S., Haseeb A., Khalid S. H., Abourehab M. A. S. Nanoemulgel, an Innovative Carrier for Diflunisal Topical Delivery with Profound Anti-Inflammatory Effect: in vitro and in vivo Evaluation. International Journal of Nanomedicine. 2021;16:1457–1472. DOI:10.2147/IJN.S294653.; Bayer I. S. Hyaluronic Acid and Controlled Release: A Review. Molecules. 2020;25(11):2649. DOI:10.3390/molecules25112649.; Shlini P., Sana F. M., Shambhavi U. Isolation and purification of hyaluronic acid like components from Ipomoea Batatas (sweet potato). European Journal of Pharmaceutical and Medical Research. 2017;4(8),282–286.; Mihajlova P. A., Generalova Ju. E. Research of the chromatographic behavior of diflunisal. In: I International Scientific and Practical Conference dedicated to the memory of Professor P. V. Kuznetsov. Chromatography in chemistry, medicine and biology: current issues, achievements and innovations. Kemerovo. 2021. P. 124–127. (In Russ.); Proksch E. pH in nature, humans and skin. The Journal of Dermatology. 2018;45(9):1044–1052. DOI:10.1111/1346-8138.14489.; https://www.pharmjournal.ru/jour/article/view/1735